ELX-02 treatment improved podocyte foot process effacement in all three patients by an average of 60% based on a blinded kidney biopsy analysis by NIPOKA GmbH Biopsy results support clinical benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback